Top 10 DMT Papers

This randomised, double-blind, placebo-controlled study investigated the subjective effects of graded doses of DMT in hallucinogen-experienced users. Effects began almost immediately after DMT administration, peaking at 90 to 120 seconds, and were almost completely resolved by 30 minutes. Hallucinogenic effects were seen after 14 and 21 mg/70kg of DMT, while lower doses, 70 and 35 mg/70kg, were primarily affective and somaesthetic (body + sensory perception). It adds a concrete angle on DMT research, helping readers understand the topic through evidence rather than broad claims alone.

Intravenous DMT markedly reduced alpha and beta oscillatory power and robustly increased spontaneous EEG signal diversity, with emergent delta/theta activity correlating with the peak, eyes‑closed visual component of the experience. These oscillatory and diversity changes closely tracked subjective reports and plasma drug levels, linking specific EEG signatures to immersive DMT states of consciousness. Its main value is mechanistic: it helps connect subjective or clinical effects to biology instead of treating the drug experience as a black box. Together with the other papers here, it helps separate what is distinctive about DMT research from claims that apply to psychedelics more broadly.

The paper was one of the first sanctioned studies using psychedelics following their classification as Schedule I substances. Participants received intravenous doses of DMT at 0. hormonal, autonomic, and cardiovascular effects were assessed. It was found that DMT can be safely administered to experienced hallucinogen users. It adds a concrete angle on DMT research, helping readers understand the topic through evidence rather than broad claims alone. Together with the other papers here, it helps separate what is distinctive about DMT research from claims that apply to psychedelics more broadly.

This within-subjects, placebo-controlled study found that the DMT experience had many overlaps with the near-death experience (NDE). It adds a concrete angle on DMT research, helping readers understand the topic through evidence rather than broad claims alone. Together with the other papers here, it helps separate what is distinctive about DMT research from claims that apply to psychedelics more broadly.

In a within-subject, placebo-controlled EEG–fMRI study of 20 volunteers, IV DMT produced robust increases in global communication between brain networks, network disintegration and desegregation, and a compression of the principal cortical gradient. These imaging changes tracked subjective intensity, correlated with PET-derived 5‑HT2A receptor maps and EEG alterations, supporting a predominant action of DMT on the transmodal association cortex rich in 5‑HT2A expression. Its main value is mechanistic: it helps connect subjective or clinical effects to biology instead of treating the drug experience as a black box.

The double-blind study of the psychological effects of esketamine and DMT found the positive effects of DMT, and the negative effects of ketamine most resembling those symptoms of schizophrenia. It adds a concrete angle on DMT research, helping readers understand the topic through evidence rather than broad claims alone. Together with the other papers here, it helps separate what is distinctive about DMT research from claims that apply to psychedelics more broadly.

This in vitro (neuronal cell culture) study investigated the anti-inflammatory effects of NN-DMT and 5-MeO-DMT (100 μM), and demonstrate that its immunomodulatory effects on the functional activities of human dendritic cells operate through the sigma-1 receptor. Its main value is mechanistic: it helps connect subjective or clinical effects to biology instead of treating the drug experience as a black box. Together with the other papers here, it helps separate what is distinctive about DMT research from claims that apply to psychedelics more broadly.

The review (2018) presents the historical research into DMT, focussing on its biosynthesis, metabolism, sites of action, methods of detection, and potential physiological and therapeutic roles. The author proposes several areas for further research and highlights the need to resolve the role of endogenous DMT. It adds a concrete angle on DMT research, helping readers understand the topic through evidence rather than broad claims alone. Together with the other papers here, it helps separate what is distinctive about DMT research from claims that apply to psychedelics more broadly.

The rat study with DMT found that it reduced anxiety by extinguishing of cued fear memory and reduces immobility in the forced swim test (a proxy for depression). It adds a concrete angle on DMT research, helping readers understand the topic through evidence rather than broad claims alone. Together with the other papers here, it helps separate what is distinctive about DMT research from claims that apply to psychedelics more broadly.

The review of case reports found that psychotic episodes following ayahuasca or DMT use are rare but have been documented in both ritual and recreational/non‑controlled settings. Most reported cases involved a personal or family history of psychosis, bipolar/manic disorders or concomitant substance use, supporting psychiatric screening before administration and avoidance of hallucinogens in those with such histories. That makes it useful as a map of DMT research: it shows where evidence clusters, where the field is thin, and which claims need more cautious reading.